Publicaciones (64) Publicaciones de IGNACIO ALGARRA LOPEZ DE DIEGO

2022

  1. Differential Immunometabolic Effects of High-Fat Diets Containing Coconut, Sunflower, and Extra Virgin Olive Oils in Female Mice

    Molecular Nutrition and Food Research, Vol. 66, Núm. 18

2021

  1. MHC heterogeneity and response of metastases to immunotherapy

    Cancer and Metastasis Reviews, Vol. 40, Núm. 2, pp. 501-517

2020

  1. MHC class i molecules and cancer progression: Lessons learned from preclinical mouse models

    Cancer Immunology: A Translational Medicine Context, Second Edition (Springer International Publishing), pp. 189-204

  2. Restoration of mhc-i on tumor cells by fhit transfection promotes immune rejection and acts as an individualized immunotherapeutic vaccine

    Cancers, Vol. 12, Núm. 6, pp. 1-21

  3. The high-fat diet based on extra-virgin olive oil causes dysbiosis linked to colorectal cancer prevention

    Nutrients, Vol. 12, Núm. 6, pp. 1-17

2018

  1. MHC intratumoral heterogeneity may predict cancer progression and response to immunotherapy

    Frontiers in Immunology, Vol. 9, Núm. JAN

  2. Transferencia de prácticas docentes de trabajo cooperativo del ámbito pre-universitario a la docencia práctica en la Universidad de Jaén

    Metodologías docentes innovadoras en la enseñanza universitaria (Servicio de Publicaciones de la Universidad de Murcia), pp. 107-116

2015

  1. Mhc class i molecules and cancer progression: Lessons learned from preclinical mouse models

    Cancer Immunology: A Translational Medicine Context (Springer Berlin Heidelberg), pp. 161-175

2014

  1. T lymphocytes restrain spontaneous metastases in permanent dormancy

    Cancer Research, Vol. 74, Núm. 7, pp. 1958-1968

2012

  1. MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells

    Carcinogenesis, Vol. 33, Núm. 3, pp. 687-693

  2. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells

    Journal of Pathology, Vol. 227, Núm. 3, pp. 367-379

2011

  1. Immunotherapy eradicates metastases with reversible defects in MHC class i expression

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 9, pp. 1257-1268

2010

  1. Alterations of HLA class i expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

    Cancer Immunology, Immunotherapy, Vol. 59, Núm. 1, pp. 13-26

  2. The escape of cancer from T lymphocytes: Immunoselection of MHC class i loss variants harboring structural-irreversible "hard" lesions

    Cancer Immunology, Immunotherapy, Vol. 59, Núm. 10, pp. 1601-1606

2008

  1. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis.

    BMC cancer, Vol. 8, pp. 78

2007

  1. Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response

    International Journal of Cancer, Vol. 121, Núm. 9, pp. 2023-2030

2006

  1. A new extract of the plant calendula officinalis produces a dual in vitro effect: Cytotoxic anti-tumor activity and lymphocyte activation

    BMC Cancer, Vol. 6

  2. Aceite de oliva y cáncer: componentes bioactivos con capacidad antitumoral

    Avances en Oncología básica y aplicada (Editorial Universidad de Granada), pp. 505-534

2005

  1. Aceite de oliva en la salud y en la enfermedad

    Proyectos de investigación (2003-2004) (Universidad de Jaén), pp. 309-370

2004

  1. Modification of phagocytosis and cytokine production in peritoneal and splenic murine cells by erythromycin A, azithromycin and josamycin

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 2, pp. 367-370